Novel methods in adrenal research: a metabolomics approach

[1]  Martin Fassnacht,et al.  Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma. , 2019, European journal of endocrinology.

[2]  M. Manzoni,et al.  Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging. , 2019, Journal of proteomics.

[3]  Carsten Denkert,et al.  MALDI‐Imaging for Classification of Epithelial Ovarian Cancer Histotypes from a Tissue Microarray Using Machine Learning Methods , 2018, Proteomics. Clinical applications.

[4]  V. Chortis,et al.  The role of steroid metabolome analysis for the diagnosis and follow-up of adrenocortical tumors. , 2018, Minerva endocrinologica.

[5]  M. Speicher,et al.  Current and future perspectives of liquid biopsies in genomics-driven oncology , 2018, Nature Reviews Genetics.

[6]  A. Ewing,et al.  On-Tissue Chemical Derivatization of Catecholamines Using 4-( N-Methyl)pyridinium Boronic Acid for ToF-SIMS and LDI-ToF Mass Spectrometry Imaging. , 2018, Analytical chemistry.

[7]  R. Casadonte,et al.  Digital PCR After MALDI–Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma , 2018, Proteomics. Clinical applications.

[8]  B. Heijs,et al.  Mass spectrometry imaging: How will it affect clinical research in the future? , 2018, Expert review of proteomics.

[9]  Jay-Jiguang Zhu,et al.  Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors , 2018, Acta neuropathologica communications.

[10]  P. Romagnoli,et al.  Human fetal adrenal cells retain age‐related stem‐ and endocrine‐differentiation potential in culture , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  T. MacDonald,et al.  Rapid discrimination of pediatric brain tumors by mass spectrometry imaging , 2018, Journal of Neuro-Oncology.

[12]  H. Olsson,et al.  Endogenous expression mapping of malignant melanoma by mass spectrometry imaging , 2018, Clinical and Translational Medicine.

[13]  D. Aust,et al.  Metabolome-guided genomics to identify mutations in isocitrate dehydrogenase, fumarate hydratase and succinate dehydrogenase genes in pheochromocytoma and paraganglioma , 2018, Genetics in Medicine.

[14]  T. Pons,et al.  Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients , 2018, Genetics in Medicine.

[15]  B. Shuch,et al.  Krebs Cycle-Deficient Hereditary Cancer Syndromes are Defined by Homologous Recombination DNA Repair Defects , 2018, Nature Genetics.

[16]  W. Arlt,et al.  Monogenic Disorders of Adrenal Steroidogenesis , 2018, Hormone Research in Paediatrics.

[17]  S. Tevosian,et al.  Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism , 2018, The Journal of clinical endocrinology and metabolism.

[18]  Zhongming Zhao,et al.  Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers , 2018, Cell reports.

[19]  P. de Vos,et al.  Long-term viability and function of transplanted islets macroencapsulated at high density are achieved by enhanced oxygen supply , 2018, Scientific Reports.

[20]  R. Crystal,et al.  Biology of the Adrenal Gland Cortex Obviates Effective Use of Adeno-Associated Virus Vectors to Treat Hereditary Adrenal Disorders. , 2018, Human gene therapy.

[21]  C. Ludwig,et al.  Oncogenic IDH1 Mutations Promote Enhanced Proline Synthesis through PYCR1 to Support the Maintenance of Mitochondrial Redox Homeostasis , 2018, Cell reports.

[22]  Aubry K. Miller,et al.  Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry , 2018, Acta neuropathologica communications.

[23]  Na Sun,et al.  High-Resolution Tissue Mass Spectrometry Imaging Reveals a Refined Functional Anatomy of the Human Adult Adrenal Gland , 2018, Endocrinology.

[24]  Graeme Eisenhofer,et al.  Plasma Steroid Metabolome Profiling for Diagnosis and Subtyping Patients with Cushing Syndrome. , 2018, Clinical chemistry.

[25]  Ó. Pozo,et al.  SULFATION PATHWAYS: Alternate steroid sulfation pathways targeted by LC-MS/MS analysis of disulfates: application to prenatal diagnosis of steroid synthesis disorders. , 2018, Journal of molecular endocrinology.

[26]  U. Srirangalingam,et al.  Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells , 2018, Cell reports.

[27]  F. Beuschlein,et al.  The impact of Connshing's syndrome - mild cortisol excess in primary aldosteronism drives diabetes risk. , 2017, Journal of hypertension.

[28]  P. Kapur,et al.  Oncometabolites: A New Paradigm for Oncology, Metabolism, and the Clinical Laboratory. , 2017, Clinical chemistry.

[29]  Dylan Lewis,et al.  A 13-Steroid Serum Panel Based on LC-MS/MS: Use in Detection of Adrenocortical Carcinoma. , 2017, Clinical chemistry.

[30]  W. Young,et al.  High-Resolution, Accurate-Mass (HRAM) Mass Spectrometry Urine Steroid Profiling in the Diagnosis of Adrenal Disorders. , 2017, Clinical chemistry.

[31]  Li Zhang,et al.  Delivery strategies of the CRISPR‐Cas9 gene‐editing system for therapeutic applications , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Morgan R Alexander,et al.  The 3D OrbiSIMS—label-free metabolic imaging with subcellular lateral resolution and high mass-resolving power , 2017, Nature Methods.

[33]  Roman Jaksik,et al.  Proteome profiles of different types of thyroid cancers , 2017, Molecular and Cellular Endocrinology.

[34]  C. Haglund,et al.  N‐Glycomic Profiling of Pheochromocytomas and Paragangliomas Separates Metastatic and Nonmetastatic Disease , 2017, The Journal of clinical endocrinology and metabolism.

[35]  Martin J. Lohse,et al.  Single-molecule imaging reveals receptor–G protein interactions at cell surface hot spots , 2017, Nature.

[36]  M. Lohse,et al.  Internalized TSH receptors en route to the TGN induce local Gs-protein signaling and gene transcription , 2017, Nature Communications.

[37]  Adam K. Glaser,et al.  Multiplexed Optical Imaging of Tumor-Directed Nanoparticles: A Review of Imaging Systems and Approaches , 2017, Nanotheranostics.

[38]  Yen-Hung Lin,et al.  Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years , 2017, Journal of hypertension.

[39]  M. Esteller,et al.  Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer–Predisposing Mutations in Pheochromocytomas and Paragangliomas , 2017, Clinical Cancer Research.

[40]  A. Longatto-Filho,et al.  GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior , 2017, OncoTarget.

[41]  Joanna Polanska,et al.  Molecular profiles of thyroid cancer subtypes: Classification based on features of tissue revealed by mass spectrometry imaging. , 2017, Biochimica et biophysica acta. Proteins and proteomics.

[42]  S. Ellis,et al.  Laser post-ionisation combined with a high resolving power orbitrap mass spectrometer for enhanced MALDI-MS imaging of lipids. , 2017, Chemical communications.

[43]  A. Lane,et al.  Exploring cancer metabolism using stable isotope-resolved metabolomics (SIRM) , 2017, The Journal of Biological Chemistry.

[44]  W. Arlt,et al.  Diagnosis of a malignant adrenal mass: the role of urinary steroid metabolite profiling , 2017, Current opinion in endocrinology, diabetes, and obesity.

[45]  Michael Biehl,et al.  Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism , 2017, JCI insight.

[46]  Yen-Hung Lin,et al.  Risk of Fracture in Primary Aldosteronism: A Population‐Based Cohort Study , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[47]  B. Klink,et al.  Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing. , 2017, The Clinical biochemist. Reviews.

[48]  R. Caprioli,et al.  Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms. , 2016, Journal of the American Academy of Dermatology.

[49]  Marissa Fessenden,et al.  Metabolomics: Small molecules, single cells , 2016, Nature.

[50]  Na Sun,et al.  High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue , 2016, Nature Protocols.

[51]  E. Bessonova,et al.  Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma , 2016, Hormones and Cancer.

[52]  Erwin G. Van Meir,et al.  Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase , 2016, Clinical Cancer Research.

[53]  Hans Clevers,et al.  Modeling Development and Disease with Organoids , 2016, Cell.

[54]  R. Langer,et al.  How Suitable is Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight for Metabolite Imaging from Clinical Formalin-Fixed and Paraffin-Embedded Tissue Samples in Comparison to Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance Mass Spectrometry? , 2016, Analytical chemistry.

[55]  Steven A. Brown,et al.  Circadian Metabolomics: Insights for Biology and Medicine , 2016 .

[56]  U. Schubert,et al.  Multigrid MALDI mass spectrometry imaging (mMALDI MSI) , 2016, Analytical and Bioanalytical Chemistry.

[57]  Nick Barker,et al.  Organoids as an in vitro model of human development and disease , 2016, Nature Cell Biology.

[58]  B. Klink,et al.  Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas. , 2016, The Journal of clinical endocrinology and metabolism.

[59]  Stefan R Bornstein,et al.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[60]  C. Thompson,et al.  The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.

[61]  L. McDonnell,et al.  Mass spectrometry imaging of amino neurotransmitters: a comparison of derivatization methods and application in mouse brain tissue , 2016, Metabolomics.

[62]  Graeme Eisenhofer,et al.  Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas , 2016, Hypertension.

[63]  M. Blankenstein,et al.  Comparison of 7 Published LC-MS/MS Methods for the Simultaneous Measurement of Testosterone, Androstenedione, and Dehydroepiandrosterone in Serum. , 2015, Clinical chemistry.

[64]  A. Longatto-Filho,et al.  Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors , 2015, Oncotarget.

[65]  Christian M. Metallo,et al.  Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism , 2015, Nature Communications.

[66]  F. Beuschlein,et al.  Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry. , 2015, European journal of endocrinology.

[67]  P. Bénit,et al.  In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma , 2015, Clinical Cancer Research.

[68]  R. Langer,et al.  High‐resolution MALDI‐FT‐ICR MS imaging for the analysis of metabolites from formalin‐fixed, paraffin‐embedded clinical tissue samples , 2015, The Journal of pathology.

[69]  B. Keevil,et al.  Mass spectrometry and immunoassay: how to measure steroid hormones today and tomorrow. , 2015, European journal of endocrinology.

[70]  I. Norton,et al.  MALDI mass spectrometry imaging analysis of pituitary adenomas for near-real-time tumor delineation , 2015, Proceedings of the National Academy of Sciences.

[71]  A. Tischler,et al.  SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) , 2015, Modern Pathology.

[72]  M. Loda,et al.  Innovation in metabolomics to improve personalized healthcare , 2015, Annals of the New York Academy of Sciences.

[73]  I. Kema,et al.  Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors , 2015, Hormones and Cancer.

[74]  L. Guasti,et al.  New Directions for the Treatment of Adrenal Insufficiency , 2015, Front. Endocrinol..

[75]  Juan F. García,et al.  Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene. , 2015, Journal of the National Cancer Institute.

[76]  K. Dreisewerd,et al.  Mass spectrometry imaging with laser-induced postionization , 2015, Science.

[77]  C. Stratakis,et al.  Metabolome Profiling by HRMAS NMR Spectroscopy of Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological Implications12 , 2015, Neoplasia.

[78]  E. Letouzé,et al.  Oncometabolites‐driven tumorigenesis: From genetics to targeted therapy , 2014, International journal of cancer.

[79]  S. Wiemann,et al.  Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad. , 2014, Endocrine-related cancer.

[80]  Juergen A. Knoblich,et al.  Organogenesis in a dish: Modeling development and disease using organoid technologies , 2014, Science.

[81]  F. Beuschlein,et al.  Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency. , 2014, The Journal of clinical endocrinology and metabolism.

[82]  H. Bayır,et al.  Improved spatial resolution of matrix-assisted laser desorption/ionization imaging of lipids in the brain by alkylated derivatives of 2,5-dihydroxybenzoic acid. , 2014, Rapid communications in mass spectrometry : RCM.

[83]  C. Borchers,et al.  Comprehensive imaging of porcine adrenal gland lipids by MALDI-FTMS using quercetin as a matrix. , 2014, Analytical chemistry.

[84]  P. Bachellier,et al.  Metabolomic profile of the adrenal gland: from physiology to pathological conditions. , 2013, Endocrine-related cancer.

[85]  Malte Buchholz,et al.  MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large‐scale tissue microarrays , 2013, International journal of cancer.

[86]  G. Schackert,et al.  Accumulation of 2-hydroxyglutarate is not a biomarker for malignant progression in IDH-mutated low-grade gliomas. , 2013, Neuro-oncology.

[87]  R. Rodenburg,et al.  Genotype-Specific Abnormalities in Mitochondrial Function Associate with Distinct Profiles of Energy Metabolism and Catecholamine Content in Pheochromocytoma and Paraganglioma , 2013, Clinical Cancer Research.

[88]  A. Chan,et al.  Diagnosis of 5α–reductase 2 deficiency: is measurement of dihydrotestosterone essential? , 2013, International Journal of Pediatric Endocrinology.

[89]  W. Linehan,et al.  Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. , 2012, The Journal of urology.

[90]  Kazuwa Nakao,et al.  Differentiation of human embryonic stem cells and human induced pluripotent stem cells into steroid-producing cells. , 2012, Endocrinology.

[91]  G. Siuzdak,et al.  Innovation: Metabolomics: the apogee of the omics trilogy , 2012, Nature Reviews Molecular Cell Biology.

[92]  Ovidiu C. Andronesi,et al.  Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy , 2012, Science Translational Medicine.

[93]  C. Shackleton,et al.  A Missense Mutation in the Human Cytochrome b5 Gene causes 46,XY Disorder of Sex Development due to True Isolated 17,20 Lyase Deficiency , 2011, The Journal of clinical endocrinology and metabolism.

[94]  M. Dattani,et al.  Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency , 2011, The Journal of clinical endocrinology and metabolism.

[95]  Michael Biehl,et al.  Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors , 2011, The Journal of clinical endocrinology and metabolism.

[96]  A. Wallace,et al.  Pitfalls in the Diagnosis of 5α-Reductase Type 2 Deficiency during Early Infancy , 2011, Hormone Research in Paediatrics.

[97]  G. Fava,et al.  Psychological assessment of primary aldosteronism: a controlled study. , 2011, Journal of Clinical Endocrinology and Metabolism.

[98]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[99]  V. Montori,et al.  Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. , 2010, The Journal of clinical endocrinology and metabolism.

[100]  G. Lavery,et al.  Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS) , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[101]  E. van Marck,et al.  An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. , 2009, The Lancet. Oncology.

[102]  S. Hahner,et al.  Therapeutic management of adrenal insufficiency. , 2009, Best practice & research. Clinical endocrinology & metabolism.

[103]  J. Svartberg,et al.  Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. , 2008, European journal of endocrinology.

[104]  O. Kämpe,et al.  Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency , 2008, Clinical endocrinology.

[105]  R. Lifton,et al.  A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. , 2008, The Journal of clinical endocrinology and metabolism.

[106]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[107]  Z. Hochberg,et al.  Metabolic evidence for impaired 17alpha-hydroxylase activity in a kindred bearing the E305G mutation for isolate 17,20-lyase activity. , 2008, European journal of endocrinology.

[108]  G. Johannsson,et al.  Premature mortality in patients with Addison's disease: a population-based study. , 2006, The Journal of clinical endocrinology and metabolism.

[109]  M. Ermani,et al.  Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. , 2006, The Journal of clinical endocrinology and metabolism.

[110]  Jacques Simard,et al.  Molecular Biology of the 3-Hydroxysteroid Dehydrogenase/5-4 Isomerase Gene Family , 2005 .

[111]  C. Shackleton,et al.  Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study , 2004, The Lancet.

[112]  E. Jabs,et al.  Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome , 2004, Nature Genetics.

[113]  Kenneth L. Jones,et al.  The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens. , 2002, The Journal of clinical endocrinology and metabolism.

[114]  E. Husebye,et al.  Subjective health status in Norwegian patients with Addison’s disease * , 2002, Clinical endocrinology.

[115]  J. Milbrandt,et al.  Nuclear receptor steroidogenic factor 1 directs embryonic stem cells toward the steroidogenic lineage , 1997, Molecular and cellular biology.

[116]  C. Shackleton,et al.  Urinary free cortisone and the assessment of 11β‐hydroxysteroid dehydrogenase activity in man , 1996, Clinical endocrinology.

[117]  B. Walker,et al.  11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. , 1995, The Journal of clinical endocrinology and metabolism.

[118]  T. Pickering,et al.  Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. , 1992, The Journal of clinical endocrinology and metabolism.

[119]  R. Tedde,et al.  Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. , 1992, The Journal of clinical endocrinology and metabolism.

[120]  C. Edwards,et al.  Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. , 1988, The Journal of clinical investigation.

[121]  G. E. Joannou.  Identification of 15β-hydroxylated c21 steroids in the neo-natal period: The role of 3α, 15β,17α-trihydroxy-5β-pregnan-20-one in the perinatal diagnosis of congenital adrenal hyperplasia (cah) due to a 21-hydroxylase deficiency , 1981 .

[122]  C. Gomez-Sanchez,et al.  DIAGNOSIS OF ENDOCRINE DISEASE 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids? , 2017 .

[123]  N. Zelinska.  Вроджена гіперплазія надниркових залоз внаслідок дефіциту 21-гідроксилази. Клінічні практичні настанови Ендокринологічного Товариства. Частина 1 , 2018 .

[124]  I. Dunn,et al.  Rapid Mass Spectrometry Imaging to Assess the Biochemical Profile of Pituitary Tissue for Potential Intraoperative Usage. , 2017, Advances in cancer research.

[125]  E. Patel,et al.  Fresh Frozen Versus Formalin-Fixed Paraffin Embedded for Mass Spectrometry Imaging. , 2017, Methods in molecular biology.

[126]  A. Walch,et al.  In Situ Metabolomics in Cancer by Mass Spectrometry Imaging , 2017, Advances in cancer research.

[127]  K. Pacak,et al.  Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings. , 2014, Endocrinology.

[128]  F. Beuschlein,et al.  Mitotane therapy in adrenocortical cancer induces CYP 3 A 4 and inhibits 5-reductase , explaining the need for personalized glucocorticoid and androgen replacement , 2012 .

[129]  W. Kaelin,et al.  Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases. , 2011, Cold Spring Harbor symposia on quantitative biology.

[130]  R. Cooks,et al.  Molecular imaging of adrenal gland by desorption electrospray ionization mass spectrometry. , 2010, The Analyst.

[131]  Jacques Simard,et al.  Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. , 2005, Endocrine reviews.

[132]  E. Moszczyńska,et al.  Definitive diagnosis of enzymatic deficiencies of steroidogenesis in at-risk newborns and infants by urinary marker analysis using GC/MS-SIM. , 1997, Hormone Research.

[133]  J. Trottier,et al.  Book Review: Mass Spectrometry: Principles and Applications. E. de Hoffman, J. Charette and W. Stroobant. Wiley, Chichester 1996. ISBN 0 471 96697 5 , 1997 .

[134]  S. Ulick,et al.  Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension. , 1982, Clinical and experimental hypertension. Part A, Theory and practice.

[135]  G. E. Joannou.  Identification of 15 beta-hydroxylated C21 steroids in the neo-natal period: the role of 3 alpha,15 beta,17 alpha-trihydroxy-5 beta-pregnan-20-one in the perinatal diagnosis of congenital adrenal hyperplasia (CAH) due to a 21-hydroxylase deficiency. , 1981, Journal of Steroid Biochemistry.